Home › Companies › UROGEN PHARMA LTD. › 2024-2025
Compiled from SEC Form N-PX filings and UROGEN PHARMA LTD.’s Form 8-K, filed August 8, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of August 6, 2024: 12 items on UROGEN PHARMA LTD.’s Form 8-K, filed August 8, 2024: 8 elected · 4 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore UROGEN PHARMA LTD. in the interactive database Compare manager voting policies
These tallies are UROGEN PHARMA LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 8, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Arie Belldegrun, M.D., FACS | 24,210,538 | -- | -- | 2,096,113 | 6,748,640 | 92% | Elected | — |
| Elect Director: Elizabeth Barrett | 26,265,811 | -- | -- | 40,840 | 6,748,640 | 99.8% | Elected | — |
| Elect Director: Cynthia M. Butitta | 25,614,657 | -- | -- | 691,994 | 6,748,640 | 97% | Elected | — |
| Elect Director: Fred E. Cohen, M.D., D.Phil. | 25,753,702 | -- | -- | 552,949 | 6,748,640 | 98% | Elected | — |
| Elect Director: Stuart Holden, M.D. | 25,594,793 | -- | -- | 711,858 | 6,748,640 | 97% | Elected | — |
| Elect Director: James A. Robinson, Jr. | 26,184,412 | -- | -- | 122,239 | 6,748,640 | 99.5% | Elected | — |
| Elect Director: Leana S. Wen, M.D., M.Sc. | 26,092,046 | -- | -- | 214,605 | 6,748,640 | 99.1% | Elected | — |
| Elect Director: Daniel G. Wildman | 26,274,644 | -- | -- | 32,007 | 6,748,640 | 99.8% | Elected | — |
| 2. 2024 Compensation Policy | 22,359,904 | 3,433,075 | 513,672 | -- | 6,748,640 | 87% | Approved | — |
| 3. 2017 Amended Plan | 22,707,108 | 3,050,813 | 548,730 | -- | 6,748,640 | 88% | Approved | — |
| 4. Advisory vote on the compensation of the Company's named executive officers | 22,609,477 | 3,143,555 | 553,619 | -- | 6,748,640 | 88% | Approved | — |
| 5. Engagement of PricewaterhouseCoopers LLP as independent auditor | 33,039,893 | 8,345 | 7,053 | -- | 0 | 99.9% | Approved | — |
Source: UROGEN PHARMA LTD., Form 8-K, filed with the SEC on August 8, 2024 — read the filing on EDGAR.
Each item below shows how the 132 asset managers that disclosed a UROGEN PHARMA LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of UROGEN PHARMA LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Arie Belldegrun, M.D., FACS”): 24,210,538 for, 2,096,113 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 290,568 for, 421,528 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 313,975 | Withhold |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 26,860 | 0 | 0 | 9,228 | Mixed |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 16,400 | Withhold |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 15,289 | Withhold |
| Global X | 0 | 0 | 0 | 13,653 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 12,390 | Withhold |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 0 | 9,616 | Withhold |
| Pacific Life | 0 | 0 | 0 | 9,304 | Withhold |
| SEI | 0 | 0 | 0 | 6,702 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 6,674 | Withhold |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 3,180 | Withhold |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 0 | 1,060 | Withhold |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Cynthia M. Butitta
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Cynthia M. Butitta”): 25,614,657 for, 691,994 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 702,381 for, 9,715 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 0 | 9,616 | Withhold |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Daniel G. Wildman
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Daniel G. Wildman”): 26,274,644 for, 32,007 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 712,096 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Elizabeth Barrett
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Elizabeth Barrett”): 26,265,811 for, 40,840 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 711,096 for, 1,000 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Fred E. Cohen
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Fred E. Cohen, M.D., D.Phil.”): 25,753,702 for, 552,949 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 614,875 for, 97,221 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 9,228 | 0 | 0 | 26,860 | Mixed |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 26,724 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 16,400 | Withhold |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 15,289 | Withhold |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 4,140 | Withhold |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 2,963 | Withhold |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,816 | Withhold |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: James A. Robinson, Jr.
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: James A. Robinson, Jr.”): 26,184,412 for, 122,239 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 696,890 for, 15,206 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 12,390 | Withhold |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,816 | Withhold |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Leana S. Wen
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Leana S. Wen, M.D., M.Sc.”): 26,092,046 for, 214,605 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 676,535 for, 35,561 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 13,653 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 12,390 | Withhold |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 6,702 | Withhold |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,816 | Withhold |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect to the Board of Directors the following eight nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Stuart Holden
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Stuart Holden, M.D.”): 25,594,793 for, 711,858 withheld, per its Form 8-K filed August 8, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 - Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 712,096 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
88% Approved · of votes cast
Description as filed by funds: To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 800,000 shares.
UROGEN PHARMA LTD.’s own tally for this item (“3. 2017 Amended Plan”): 22,707,108 for, 3,050,813 against — passed, per its Form 8-K filed August 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders approved the 2017 Amended Plan.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Fund voting reports, all 37 managers: 712,096 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wildcat Capital Management, LLC | 0 | 0 | 495,606 | 0 | Abstain |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 3,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 3,000 for, 495,606 abstained.
Combines 9 wordings of this item as funds reported it.
88% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.
UROGEN PHARMA LTD.’s own tally for this item (“4. Advisory vote on the compensation of the Company's named executive officers”): 22,609,477 for, 3,143,555 against — passed, per its Form 8-K filed August 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “On an advisory basis, the shareholders approved the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 12,390 | 0 | 0 | Against |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,816 | 0 | 0 | Against |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Fund voting reports, all 37 managers: 696,890 for, 15,206 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,548,599 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 3,557,347 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 3,082,911 | 0 | 0 | 0 | For |
| MENORA MIVTACHIM HOLDINGS LTD. | 0 | 2,287,899 | 0 | 0 | Against |
| GREAT POINT PARTNERS LLC | 2,045,722 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,469,350 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 816,853 | 0 | 0 | 0 | For |
| BlackRock | 513,873 | 9,639 | 0 | 0 | For |
| Wildcat Capital Management, LLC | 0 | 0 | 495,606 | 0 | Abstain |
| DAFNA Capital Management LLC | 469,000 | 0 | 0 | 0 | For |
| State Street | 273,949 | 49 | 0 | 0 | For |
| Laurion Capital Management LP | 250,600 | 0 | 0 | 0 | For |
| Goldman Sachs | 176,375 | 0 | 0 | 0 | For |
| Wellington | 136,215 | 0 | 0 | 0 | For |
| Point72 | 103,504 | 0 | 0 | 0 | For |
| OAK RIDGE INVESTMENTS LLC | 100,017 | 0 | 0 | 0 | For |
| Northern Trust | 88,070 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 0 | 63,246 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 44,749 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 42,361 | 0 | 0 | 0 | For |
| Coastal Bridge Advisors, LLC | 33,417 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 29,055 | 0 | 0 | 0 | For |
| Two Sigma | 27,750 | 0 | 0 | 0 | For |
| Vivaldi Capital Management LP | 27,124 | 0 | 0 | 0 | For |
| AllianceBernstein | 26,860 | 0 | 0 | 0 | For |
Institutional-manager reports, all 106 managers: 18,185,211 for, 2,397,184 against, 495,606 abstained. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 0 | 13,653 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 0 | 12,390 | 0 | 0 | Against |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 0 | 9,616 | 0 | 0 | Against |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 0 | 6,702 | 0 | 0 | Against |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 3,180 | 0 | 0 | Against |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Fund voting reports, all 37 managers: 666,456 for, 45,640 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wildcat Capital Management, LLC | 0 | 0 | 495,606 | 0 | Abstain |
| DAFNA Capital Management LLC | 469,000 | 0 | 0 | 0 | For |
| BlackRock | 375,843 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 0 | 1,500 | 0 | 0 | Against |
Institutional-manager reports, all 4 managers: 844,843 for, 1,500 against, 495,606 abstained.
99.9% Approved · of votes cast
Description as filed by funds: To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's auditor until the Company's 2025 annual meeting of shareholders.
UROGEN PHARMA LTD.’s own tally for this item (“5. Engagement of PricewaterhouseCoopers LLP as independent auditor”): 33,039,893 for, 8,345 against — passed, per its Form 8-K filed August 8, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders approved the engagement of PricewaterhouseCoopers LLP as the Company's independent auditor until the Company's 2025 annual meeting of shareholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 712,096 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 313,975 | 0 | 0 | 0 | For |
| ARK ETF Trust | 151,781 | 0 | 0 | 0 | For |
| Equitable | 36,088 | 0 | 0 | 0 | For |
| Vanguard | 31,480 | 0 | 0 | 0 | For |
| Northern Trust | 26,724 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 16,154 | 0 | 0 | 0 | For |
| State Street | 15,289 | 0 | 0 | 0 | For |
| Global X | 13,653 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,390 | 0 | 0 | 0 | For |
| John Hancock | 10,660 | 0 | 0 | 0 | For |
| New York Life | 9,616 | 0 | 0 | 0 | For |
| Pacific Life | 9,304 | 0 | 0 | 0 | For |
| SEI | 6,702 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,674 | 0 | 0 | 0 | For |
| Fidelity | 5,288 | 0 | 0 | 0 | For |
| DWS | 4,140 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,200 | 0 | 0 | 0 | For |
| Charles Schwab | 3,180 | 0 | 0 | 0 | For |
| Voya | 2,963 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 2,818 | 0 | 0 | 0 | For |
| Calvert | 2,816 | 0 | 0 | 0 | For |
| ProShares | 1,672 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 1,474 | 0 | 0 | 0 | For |
| Morgan Stanley | 1,060 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 41,169,954 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 0.76% |
| 2 | ARK ETF Trust | 0.37% |
| 3 | Equitable | 0.09% |
| 4 | Vanguard | 0.08% |
| 5 | Northern Trust | 0.06% |
| 6 | Lincoln Financial | 0.04% |
| 7 | Goldman Sachs | 0.04% |
| 8 | State Street | 0.04% |
| 9 | Global X | 0.03% |
| 10 | CLEARWATER INVESTMENT TRUST | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 11.05% |
| 2 | RTW INVESTMENTS, LP | 8.64% |
| 3 | RA CAPITAL MANAGEMENT, L.P. | 7.49% |
| 4 | MENORA MIVTACHIM HOLDINGS LTD. | 5.56% |
| 5 | GREAT POINT PARTNERS LLC | 4.97% |
| 6 | Cormorant Asset Management, LP | 3.57% |
| 7 | SILVERARC CAPITAL MANAGEMENT, LLC | 1.98% |
| 8 | BlackRock | 1.27% |
| 9 | Wildcat Capital Management, LLC | 1.20% |
| 10 | DAFNA Capital Management LLC | 1.14% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| The Toronto-Dominion Bank | 6.36% | 13G |
| BlackRock | 5.89% | 13F |
| Menora Mivtachim Holdings Ltd | 5.59% | 13G |
| Soleus Capital Master Fund, L.P. | 5.31% | 13G |
| Morgan Stanley | 2.08% | 13F |
| State Street | 1.93% | 13F |
| Geode Capital | 1.15% | 13F |
| Millennium Management | 1.03% | 13F |
| JPMorgan Chase | 0.90% | 13F |
| T. Rowe Price | 0.90% | 13F |
Percentages above are of 41,169,954 shares outstanding, as reported by UROGEN PHARMA LTD. on its Form 10-Q dated June 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UROGEN PHARMA LTD.’s 10-Q dated June 30, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At UROGEN PHARMA LTD.'s shareholder meeting held August 6, 2024, in the 2024-2025 proxy season, 132 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,206 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers… — UROGEN PHARMA LTD.'s filing reports the proposal as approved, with 88% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: UROGEN PHARMA LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on August 8, 2024.
UROGEN PHARMA LTD. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.